| Literature DB >> 24269123 |
Yi-Pei Chen1, Chad C Catbagan1, Jeannette T Bowler1, Trevor Gokey1, Natalie D M Goodwin1, Anton B Guliaev1, Weiming Wu1, Taro Amagata2.
Abstract
Employing a genetically modified yeast strain as a screening tool, 4-dimethylaminobenzoic acid (5) was isolated from the marine sediment-derived Streptomyces sp. CP27-53 as a weak yeast sirtuin (Sir2p) inhibitor. Using this compound as a scaffold, a series of disubstituted benzene derivatives were evaluated to elucidate the structure activity relationships for Sir2p inhibition. The results suggested that 4-alkyl or 4-alkylaminobenzoic acid is the key structure motif for Sir2p inhibitory activity. The most potent Sir2p inhibitor, 4-tert-butylbenzoic acid (20), among the tested compounds in this study turned out to be a weak but selective SIRT1 inhibitor. The calculated binding free energies between the selected compounds and the catalytic domain of SIRT1 were well correlated to their measured SIRT1 inhibitory activities.Entities:
Keywords: 4-Dimethylaminobenzoic acid; 4-tert-Butylbenzoic acid; Class III HDAC inhibitor; Marine-derived Streptomyces sp.; Sirtuin
Mesh:
Substances:
Year: 2013 PMID: 24269123 PMCID: PMC3909564 DOI: 10.1016/j.bmcl.2013.11.004
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823